Julien Planchais

Jouy-sur-morin, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host.

Saccharomyces boulardii CNCM I-745 mitigates antibiotic-induced gut microbiome functional alterations independently of the host.

Journal: Gut microbes
Published: November 07, 2025

Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature.

Reduced intestinal GLP-1 + cell numbers are associated with an inflammation-related epithelial metabolic signature.

Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025

Reduced Intestinal GLP-1+ Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature.

Reduced Intestinal GLP-1+ Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature.

Journal: Cellular and molecular gastroenterology and hepatology
Published: May 16, 2025

Metabolomics and metagenomics in mice reveal the role of the gut microbiota in tryptophan metabolism.

Metabolomics and metagenomics in mice reveal the role of the gut microbiota in tryptophan metabolism.

Journal: iScience
Published: March 14, 2025

Correction: Gut barrier-microbiota imbalances in early life lead to higher sensitivity to inflammation in a murine model of C-section delivery.

Correction: Gut barrier-microbiota imbalances in early life lead to higher sensitivity to inflammation in a murine model of C-section delivery.

Journal: Microbiome
Published: August 04, 2023

The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism.

The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism.

Journal: Nature communications
Published: May 22, 2023

Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.

Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.

Journal: Beneficial microbes
Published: January 05, 2023

MetaPhlAn 4 profiling of unknown species-level genome bins improves the characterization of diet-associated microbiome changes in mice.

MetaPhlAn 4 profiling of unknown species-level genome bins improves the characterization of diet-associated microbiome changes in mice.

Journal: Cell reports
Published: December 28, 2022

Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9-/- mice to colitis.

Dissecting the respective roles of microbiota and host genetics in the susceptibility of Card9-/- mice to colitis.

Journal: Microbiome
Published: December 12, 2022

Gut barrier-microbiota imbalances in early life lead to higher sensitivity to inflammation in a murine model of C-section delivery.

Gut barrier-microbiota imbalances in early life lead to higher sensitivity to inflammation in a murine model of C-section delivery.

Journal: Microbiome
Published: October 06, 2022

Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem.

Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem.

Journal: Microbiome
Published: August 24, 2022

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.

Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.

Journal: Gut
Published: March 11, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026